Cargando…
Novel Carboxylated Chitosan-Based Triptolide Conjugate for the Treatment of Rheumatoid Arthritis
A new platform for triptolide (TP) delivery was prepared by conjugating TP to a carboxylmethyl chitosan (CMCS). Compared with the natural TP, the TP-conjugate (TP-CMCS) containing TP of ~5 wt% exhibited excellent aqueous solubility (>5 mg/mL). Results of in vitro experiments showed that TP-CMCS c...
Autores principales: | Zhang, Lan, Yan, Min, Chen, Kun, Tian, Qikang, Song, Junying, Zhang, Zijuan, Xie, Zhishen, Yuan, Yong, Jia, Yaquan, Zhu, Xin, Zhang, Zhenqiang, Wu, Xiangxiang, Zeng, Huahui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150988/ https://www.ncbi.nlm.nih.gov/pubmed/32110979 http://dx.doi.org/10.3390/pharmaceutics12030202 |
Ejemplares similares
-
In vivo antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration
por: Zeng, Huahui, et al.
Publicado: (2020) -
Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer
por: Zeng, Xiaohu, et al.
Publicado: (2021) -
Triptolide and l-ascorbate palmitate co-loaded micelles for combination therapy of rheumatoid arthritis and side effect attenuation
por: Li, Man, et al.
Publicado: (2022) -
The Effect of Triptolide Combined With Crocin on Arthritis in Mice: From Side Effect Attenuation to Therapy
por: Yan, Min, et al.
Publicado: (2022) -
TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment
por: Wang, Xinlong, et al.
Publicado: (2022)